Johnson & Johnson (JNJ) said late Monday that the US Bankruptcy Court for the Southern District of Texas denied its subsidiary Red River Talc's request to confirm its proposed prepackaged bankruptcy plan.
The drugmaker said it plans to return to the tort system to challenge and defeat meritless talc claims instead of pursuing an appeal.
J&J has no intention of settling or paying plaintiffs' lawyers, the company said, adding it will reverse about $7 billion of its previous reserve related to the litigation.
"As we have repeatedly stated, in the absence of plan confirmation, we will vigorously present our case in the tort system, starting with the adjudication of the motions pending in the Multi-District Litigation to exclude plaintiffs' experts and to disqualify the lead counsel for its unethical breaches," the company said.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。